Jackson Creek Investment Advisors LLC boosted its position in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 235.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,032 shares of the company's stock after buying an additional 6,341 shares during the quarter. Jackson Creek Investment Advisors LLC's holdings in Tenet Healthcare were worth $1,795,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Triumph Capital Management bought a new stake in Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare during the 4th quarter valued at $26,000. Elyxium Wealth LLC bought a new stake in Tenet Healthcare during the 4th quarter valued at $29,000. Westside Investment Management Inc. raised its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock valued at $39,000 after buying an additional 96 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the 2nd quarter valued at $35,000. 95.44% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president owned 29,291 shares of the company's stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 46,517 shares of company stock worth $10,943,111 in the last three months. 0.97% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several brokerages have commented on THC. TD Cowen restated a "buy" rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Jefferies Financial Group upped their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a "buy" rating in a report on Thursday, February 12th. Cantor Fitzgerald restated an "overweight" rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Weiss Ratings restated a "buy (b-)" rating on shares of Tenet Healthcare in a report on Friday, March 27th. Finally, KeyCorp decreased their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating for the company in a report on Friday, May 1st. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $244.16.
Get Our Latest Stock Report on THC
Tenet Healthcare Stock Up 1.8%
Shares of Tenet Healthcare stock opened at $176.92 on Wednesday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company has a 50-day moving average of $192.04 and a 200 day moving average of $202.45. The firm has a market cap of $15.24 billion, a price-to-earnings ratio of 9.20, a PEG ratio of 1.14 and a beta of 1.30. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare's quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the business earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.67 earnings per share for the current fiscal year.
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
